Intrinsic Value of S&P & Nasdaq Contact Us

Agenus Inc. AGEN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.33
+55.3%

Agenus Inc. (AGEN) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 8 recommend buying, 3 recommend holding, and 0 recommend selling.

The analyst consensus price target for AGEN is $7.33, representing a +55.3% upside from the current price of $4.72. Price targets range from a low of $7.00 to a high of $8.00.

Analyst Consensus — AGEN

Buy
Strong Buy
0
Buy
8
Hold
3
Sell
0
Strong Sell
0
11 analysts
Price Targets
Consensus$7.33
High$8.00
Low$7.00
Median$7.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg-
All-Time Count5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message